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Objective
Due to the decrease in brain death donors (BDD), dona-
tion after controlled cardiac death (Maastricht III type
patients, DCD-III) has aroused as another strategy of
donation. The objective of this research is to study the
general characteristics and the impact on donation rates
of a DCD-III protocol (Figure 1), after its implementa-
tion (January 2012), in a tertiary hospital.
Methods
Retrospective, descriptive and observational study (Janu-
ary 2012-February 2015). The DCD-III protocol
enclosed limitation of life sustaining therapies (LLST) in
both the intensive care unit (UCI) and the operating
room (OR), and included two strategies (Strategy A:
rapid surgery and Strategy B: cannulation, Figure 2).
Type and number of organs obtained, and their impact
on donation rates were analyzed.
Results
During the study period there were 73 potential donors
that turned out in 52 real donors. BDD accounted for
27 donations and DCD-III for 25 (48% increase in dona-
tions after the introduction of DCD-III). In the DCD-III
group, LLST was done in all patients but one in the OR.
Eighteen patients underwent rapid surgery. Characteris-
tics of donation and differences in organ retrieval are
shown in Figure 3. In the 2010-2012 period, monthly
organ donation rate was 0,45, and it tripled to 1,4
donors/month after the establishment of the DCD-III
protocol. Mean organ rate recovered by donor was 2,96
for BDD and 2,24 for DCD-III. DCD-III donors were
responsible for a 48,8%, 29,6% and 44,4% of the kidney,
liver and lung transplants in the study period.
Conclusions
DCD-III is a valid method for increasing organ donation
rates. DCD-III programs should form part of organ
donation strategies.
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